Director's Dealing • Jun 1, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 0370Q
Assura PLC
01 June 2018
1 June 2018
Assura plc
("the Company")
Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs")
The Company announces that Jayne Cottam, CFO and PDMR, has purchased 26,000 Ordinary Shares of 10 pence each in the Company ("Ordinary Shares") in accordance with the shareholding requirement section of the remuneration policy. Following the purchase, the total beneficial interest of Jayne Cottam and her connected persons in the Ordinary shares is 43,543 Ordinary Shares.
In addition, Genee Murphy, spouse of Jonathan Murphy, CEO and PDMR, transferred 72,300 Ordinary Shares into an ISA. Following the transfer, the total beneficial interest of Jonathan Murphy and his connected persons in the Ordinary Shares remains unchanged at 2,393,349 Ordinary Shares.
The Notification of Dealing Form for the PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jayne Cottam
2
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Share purchase for 57.5 pence per share
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.575 GBP | 26,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.575 GBP | 26,000 | £14,950 GBP |
e)
Date of the transaction
31/05/2018
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jonathan Murphy
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Share transfer by Genee Murphy (spouse) to ISA for 57.4 pence per share
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.574 GBP | 72,300 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.574 GBP | 72,300 | £41,500.20 GBP |
e)
Date of the transaction
31/05/2018
f)
Place of the transaction
XLON
Enquiries
| Assura plc | Tel: 01925 420660 |
| Orla Ball | |
| Edelman | Tel: 0203 047 2546 |
| John Kiely Brett Jacobs Rob Yates |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2018, Assura's property portfolio was valued at £1,733 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBFLFBVQFXBBV
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.